Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference66 articles.
1. Savitri AN, Azmi W. Microbial L-asparaginase: A potent antitumour enzyme. Indian J Biotechnol. 2003;2:184–94.
2. Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical evaluation of L-aspaprginase in the treatment of leukemia. Crit Rev Oncol Hematol. 2007;61:208–21.
3. Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E. Comparison of Escherichia coli–asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's leukemia group phase 3 trial. Blood. 2002;99:2734–9.
4. Ambi Rani S, Sundaram L, Vasantha P.B. A study on in vitro antioxidant and anticancer activity of L-asparaginase. J Pharm Res. 2011;5:1463–66.
5. El-Naggar NE, El-Ewasy SM, El-Shweihy NM. Microbial L-asparaginase as a potential therapeutic agent for the treatment of acute lymphoblastic leukemia: the pros and cons. Int J Pharmacol. 2014;10:182–99.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献